[Usefulness of mucoactive drugs in respiratory diseases].
Serrano
J
J
Departamento de Neumología, Hospital de la Santa Creu i de Sant Pau, Barcelona.
Sanchis
J
J
D000111:Acetylcysteine / Q000627:therapeutic use; D000551:Ambroxol / Q000627:therapeutic use; D001964:Bromhexine / Q000627:therapeutic use; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy*; D003550:Cystic Fibrosis / Q000188:drug therapy; D003850:Deoxyribonuclease I / Q000627:therapeutic use; D004146:Dioxanes / Q000627:therapeutic use; D005100:Expectorants / Q000627:therapeutic use*; D005990:Glycerol / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic
D004146:Dioxanes; D005100:Expectorants; D000551:Ambroxol; C015372:iodinated glycerol; D003850:Deoxyribonuclease I; C043484:guaimesal; D005990:Glycerol; D001964:Bromhexine; D000111:Acetylcysteine
Utilidad de los fármacos mucoactivos en enfermedades respiratorias.